Procter & Gamble Hygiene and Health Care Ltd
Procter & Gamble Hygiene and Health Care Q3 FY19 earnings call: Revenue & Margins
Q3 FY19 investor presentation: what the company reported on revenue, margins and projects.
Based on Procter & Gamble Hygiene and Health Care Ltd's Q3 FY19 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
The presentation reports sales of approximately INR 2,500 Crore (Page 16). The investor presentation does not provide any quarterly figures or year-on-year changes for EBITDA, operating margin, or profit after tax (PAT).
From Procter & Gamble Hygiene and Health Care Ltd's Q3 FY19 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- The presentation reports sales of approximately INR 2,500 Crore (Page 16).
- Sales have grown 2.5 times over the past 7 years (from INR 1,003 Cr in 2011 to INR 2,455 Cr in 2018) (Page 16).
- Profits (PAT) have also grown 2.5 times over the past 7 years (from INR 151 Cr in 2011 to INR 375 Cr in 2018) with PAT margins at 15% (Page 16).
- The compound annual growth rate (CAGR) for both sales and profits has been 14%+ over the last 7 years (Page 16).
- No explicit quarterly revenue, sales, or volume figures or year-on-year changes are provided.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Procter & Gamble Hygiene and Health Care Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Personal Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Procter & Gamble Hygiene and Health Care Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Procter & Gamble Hygiene and Health Care Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹941 Cr, net profit ₹153 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Procter & Gamble Hygiene and Health Care Ltd's management said in earlier quarters
Frequently Asked Questions
What were Procter & Gamble Hygiene and Health Care Ltd Q3 FY19 results?
The presentation reports sales of approximately INR 2,500 Crore (Page 16). The investor presentation does not provide any quarterly figures or year-on-year changes for EBITDA, operating margin, or profit after tax (PAT).
What is Procter & Gamble Hygiene and Health Care Ltd share price analysis?
Procter & Gamble Hygiene and Health Care Ltd currently shows a neutral. The stock trades at a P/E of 30.7 with a market cap of ₹24,300 Cr. Investors should review the full earnings analysis for detailed insights.
Is Procter & Gamble Hygiene and Health Care Ltd planning capital expenditure?
The presentation does not explicitly mention any capex, capacity expansion, or new plant/project details including amounts, status, or timelines.
Keep Procter & Gamble Hygiene and Health Care Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.